By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

National Cancer Institute (NCI) 

NCI Public Inquiries Office
Building, 31, Room 10A03
31 Center Drive, MSC 2

Bethesda  Maryland  20892-2580  U.S.A.
Phone: 301-435-3848 Fax:


SEARCH JOBS




Collaborations

Maxygen, Inc. 

Genzyme General 

PanVera LLC 

Panacos Pharmaceuticals Inc.  Panacos has a CRADA with leading scientists at the National Cancer Institute to study the mechanism of HIV maturation inhibitors and to discover new antiviral drugs.





Company News
Sofie Biosciences Receives $1.5M National Cancer Institute Phase 2 SBIR 10/16/2014 7:26:47 AM
Actinobac Biomed, Inc. Receives $905,000 Small Business Grant From National Cancer Institute To Advance Blood Cancer Research 10/14/2014 1:17:06 PM
Drinking Coffee May Be Good For The Liver, National Cancer Institute Study 10/9/2014 3:05:33 PM
Intensity Therapeutics, Inc.'s Research Selected For Presentation At The Annual National Cancer Institute Cancer Immunology And Immunotherapy Conference 10/9/2014 10:44:05 AM
Blaze Bioscience Inc. Announces National Cancer Institute SBIR Phase II Funding For Clinical Trial Of Tumor Paintâ„¢ BLZ-100 In Sarcoma 10/8/2014 10:10:04 AM
Advanced Cell Diagnostics, Inc. Awarded $1.4 Million National Cancer Institute Grant To Develop Ultrasensitive Diagnostic Test For B-Cell Lymphoma 10/7/2014 8:43:46 AM
National Cancer Institute Awards Kiyatec Nearly $2 Million To Advance Predictive Cancer Diagnostics 9/18/2014 10:14:43 AM
Enumeral Biomedical (ENUM) Awarded Phase II SBIR Contract From The National Cancer Institute To Advance Human Tissue Immuno-Oncology Profiling 9/17/2014 10:46:46 AM
Certain Form Of Baldness Linked To Prostate Cancer, National Cancer Institute Study 9/16/2014 6:30:08 AM
Pharmatech, Inc. Announces Research Collaboration Under Phase II National Cancer Institute/SBIR Grant With Weill Cornell Medical College 9/8/2014 9:44:18 AM
12345678910...
//-->